Related Experiment Video
Updated: Feb 4, 2026

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
Published on: August 1, 2025
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic
Federica Portale1, Giulia Cricrì1, Silvia Bresolin2
1Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM, Monza.
ActivinA is over-expressed in leukemia and promotes cancer cell migration and bone marrow engraftment. This protein enhances leukemia progression by reprogramming the bone marrow microenvironment, offering a potential therapeutic target.
Area of Science:
- Hematology
- Oncology
- Cell Biology
Background:
- B-cell precursor-acute lymphoblastic leukemia (B-ALL) alters the bone marrow (BM) niche, creating a leukemia-supportive and chemo-protective microenvironment.
- Targeting the leukemia-stroma interplay is crucial for improving B-ALL treatment outcomes.
Purpose of the Study:
- To identify novel factors involved in leukemia-stroma interactions within the BM niche.
- To investigate the role of ActivinA, a TGF-β family member, in B-ALL pathogenesis and its potential as a therapeutic target.
Main Methods:
- Quantification of ActivinA expression in leukemic and normal BM samples.
- In vitro culture of leukemic cells with mesenchymal stromal cells (MSCs).
- Analysis of leukemic cell motility and migration pathways.
- Assessment of intracellular calcium levels and actin polymerization.
- In vivo validation using a xenograft mouse model.
Main Results:
- ActivinA is over-expressed in leukemic BM and its production is induced in MSCs cultured with leukemic cells.
- Leukemic MSCs intrinsically secrete higher levels of ActivinA compared to normal MSCs.
- ActivinA enhances leukemic cell motility, CXCL12-driven migration, and invasiveness.
- ActivinA selectively increases intracellular calcium and actin polymerization in leukemic cells, impairing healthy cell migration.
- ActivinA promotes BM engraftment and metastatic potential in a mouse model.
Conclusions:
- ActivinA is a key leukemia-promoting factor that confers a migratory advantage to leukemic cells within the BM niche.
- The pro-inflammatory leukemic BM microenvironment synergizes with leukemic cells to induce stromal ActivinA production.
- ActivinA represents a promising therapeutic target for B-ALL by disrupting leukemia-stroma interactions and enhancing disease progression.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Transcription Factors
Cell Specific Gene Expression
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...

